Last reviewed 01/2018

This drug is metabolised to an active compound, penciclovir, and has a better absorption and longer duration of action than acyclovir, allowing a three-times daily dose.

It is licensed as tablets for the treatment of zoster.

Check the summary of product characteristics before prescribing this drug.